|
PHF5A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.631860E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.275700E-03 |
| Normal-vs-Stage2 |
9.719700E-02 |
| Normal-vs-Stage3 |
1.209570E-02 |
| Normal-vs-Stage4 |
5.898800E-03 |
| Stage1-vs-Stage2 |
8.093400E-01 |
| Stage1-vs-Stage3 |
8.972000E-01 |
| Stage1-vs-Stage4 |
3.745000E-01 |
| Stage2-vs-Stage3 |
7.497000E-01 |
| Stage2-vs-Stage4 |
3.645600E-01 |
| Stage3-vs-Stage4 |
3.669000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.119550E-02 |
| Normal-vs-AfricanAmerican |
6.441600E-04 |
| Normal-vs-Asian |
3.981700E-02 |
| Caucasian-vs-AfricanAmerican |
1.462840E-01 |
| Caucasian-vs-Asian |
4.553600E-01 |
| AfricanAmerican-vs-Asian |
6.377600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.438110E-02 |
| Normal-vs-Female |
1.439630E-02 |
| Male-vs-Female |
8.409200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.797650E-02 |
| Normal-vs-Extreme_Weight |
2.983800E-02 |
| Normal-vs-Obese |
2.211600E-02 |
| Normal-vs-Extreme_Obese |
5.201700E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.171200E-01 |
| Normal_Weight-vs-Obese |
7.190200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.361600E-01 |
| Extreme_Weight-vs-Obese |
7.716200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.525600E-01 |
| Obese-vs-Extreme_Obese |
3.329200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.146200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.040000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.921890E-03 |
| Normal-vs-Age(81-100Yrs) |
9.784800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.077000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.948400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.509600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.842370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.846220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.534200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.249800E-02 |
| Normal-VS-Type2 PRCC |
1.482630E-03 |
| Normal-VS-KIRP CIMP |
1.951750E-02 |
| Normal-VS-Unclassified PRCC |
6.789900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.390300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.070400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.620200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.692800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.516800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.897000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.319700E-03 |
| Normal-vs-N1 |
2.849500E-02 |
| Normal-vs-N2 |
8.207400E-01 |
| N0-vs-N1 |
7.441600E-01 |
| N0-vs-N2 |
7.501400E-01 |
| N1-vs-N2 |
8.050600E-01 |
|
|
